Ovarian cancer: Patterns of surgical care across the United States

被引:89
作者
Goff, Barbara A.
Matthews, Barbara J.
Wynn, Michelle
Muntz, Howard G.
Lishner, Denise M.
Baldwin, Laura-Mae
机构
[1] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Family Med, Seattle, WA 98195 USA
[3] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA 30333 USA
[4] Virginia Mason Med Ctr, Sect Gynecol & Gynecol Oncol, Seattle, WA 98101 USA
关键词
ovarian cancer; surgical care;
D O I
10.1016/j.ygyno.2006.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To describe the primary surgical procedures and procedures for intraoperative and postoperative complications, and factors associated with these procedures, in women with ovarian cancer. Methods. Using hospital discharge data from nine states, obtained from the Heath Care Cost and Utilization Project from 1999 to 2002, we evaluated 10,432 women with a primary diagnosis of ovarian cancer who underwent at least an oophorectomy for additional procedural ICD-9 codes during their initial hospitalization. Results. Surgical procedures performed in addition to oophorectomy included: omentectomy/debulking 81.9%, hysterectomy 73.4%, lymph node dissection 41.4%, appendectomy 23.8%, bowel procedures 19.8%, laparoscopy 5.6%, diaphragmatic procedures 4.9%, colostomy 3.5%, and splenectomy 1.2%. Transfusions were given to 15.5% of patients. Intraoperative and postoperative procedures for complications were coded in 7.4% of patients, including repair of surgical injury 3.5%, procedures for cardiopulmonary complications 2.8%, reoperation 1.1%, and infection treatment 0.3%. In early stage disease 21.4% of women received no additional staging procedures and 46.8% did not have nodal sampling. In bivariate analysis of crude rates, factors associated with lymph node dissection were patient age, race, payer, teaching hospital status, hospital and surgeon volume, and surgeon specialty, p < .01. for all observations. Colostomies were performed by general surgeons in 23.1% of cases, by gynecologic oncologists in 2.7% of cases, and by obstetrician/gynecologists in no cases, p < .001. Complications were associated with age, payer, median household income, and stage, p < .001 for all observations. Complication rates were similar for low- and high-volume hospitals and surgeons. However, in higher volume settings, significantly more patients received debulking procedures, lymph node dissections, and additional surgical procedures, p < .001 for all observations. Conclusions. A significant percentage of women with ovarian cancer did not receive recommended surgical procedures. Almost 50% of women with early stage disease were not adequately staged and in women with advanced disease, the percentage who had additional surgical procedures such as bowel resections was much lower than in institutions that report high optimal cytoreduction rates. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 29 条
[1]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[2]  
[Anonymous], 1994, Gynecol Oncol, V55, pS4
[3]   Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer [J].
Bristow, RE ;
Montz, FJ ;
Lagasse, LD ;
Leuchter, RS ;
Karlan, BY .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :278-287
[4]   Ovarian cancer surgery in Maryland: volume-based access to care [J].
Bristow, RE ;
Zahurak, ML ;
del Carmen, MG ;
Gordon, TA ;
Fox, HE ;
Trimble, EL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2004, 93 (02) :353-360
[5]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[6]   A population-based study of patterns of care for ovarian cancer: Who is seen by a gynecologic oncologist and who is not? [J].
Carney, ME ;
Lancaster, JM ;
Ford, C ;
Tsodikov, A ;
Wiggins, CL .
GYNECOLOGIC ONCOLOGY, 2002, 84 (01) :36-42
[7]   Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].
Chi, DS ;
Franklin, CC ;
Levine, DA ;
Akselrod, F ;
Sabbatini, P ;
Jarnagin, WR ;
DeMatteo, R ;
Poynor, EA ;
Abu-Rustum, NR ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654
[8]   The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition [J].
Clark, TJ ;
Herod, JJO ;
Kehoe, S ;
Luesley, DM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (04) :468-470
[9]   Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients [J].
Earle, CC ;
Schrag, D ;
Neville, BA ;
Yabroff, KR ;
Topor, M ;
Fahey, A ;
Trimble, EL ;
Bodurka, DC ;
Bristow, RE ;
Carney, M ;
Warren, JL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (03) :172-180
[10]   THE IMPACT OF SUBSPECIALTY TRAINING ON THE MANAGEMENT OF ADVANCED OVARIAN-CANCER [J].
EISENKOP, SM ;
SPIRTOS, NM ;
MONTAG, TW ;
NALICK, RH ;
WANG, HJ .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :203-209